Sudarshan Pharma Industries Ltd

📌 Sudarshan Pharma Issues $10M in 8% FCCBs—With Option to Double Amount 💰

- Approved $10,000,000 in 8% senior unsecured FCCBs, due 2029.

- Option to issue additional $10,000,000 FCCBs within 60 days under identical terms.

- Each FCCB ($1,000 face value) convertible to equity shares at Rs. 30.19 per share.

- Board approval granted on May 21, 2026, at Mumbai headquarters.

- Bonds credited on May 21, 2026, pending fund receipt and regulatory compliance.